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In eukaryotic cells the concentration of dNTP is highest in S phase and
lowest in G1 phase and is controlled by ribonucleotide reductase
(RNR). RNR activity is eliminated in all eukaryotes in G1 phase by a
variety of mechanisms: transcriptional regulation, small inhibitory
proteins, and protein degradation. After activation of RNR upon
commitment to S phase, dATP feedback inhibition ensures that the
dNTP concentration does not exceed a certain maximal level. It is not
apparent why limitation of dNTP concentration is necessary in G1
phase. In principle, dATP feedback inhibition should be sufficient to
couple dNTP production to utilization. We demonstrate that in Sac-
charomyces cerevisiae constitutively high dNTP concentration tran-
siently arrests cell cycle progression in late G1 phase, affects activation
of origins of replication, and inhibits the DNA damage checkpoint. We
propose that fluctuation of dNTP concentration controls cell cycle
progression and the initiation of DNA replication.
DNA replication  ribonucleotide reductase
The concentration of dNTP, the precursors for DNA synthesis,fluctuates during the eukaryotic cell cycle because of changes
in the activity of ribonucleotide reductase (RNR). This enzyme
catalyzes the rate-limiting step in the biosynthesis of all four dNTPs
and is regulated by multiple mechanisms (1–4). The enzyme’s
allosteric activity site controls the concentration of dNTP: when
[dNTP] reach a certain level, the RNR activity is down-regulated
by dATP feedback inhibition (5).
In addition to the allosteric control, RNR activity is tightly cell
cycle-regulated and is restricted to S, G2, and M phases (1, 6). In
eukaryotes RNR consists of a large and a small subunit, both
necessary for catalysis. In mammalian cells elimination of RNR
activity in G1 is achieved by anaphase-promoting complex Cdh1-
dependent degradation of the small RNR subunit in mitosis and by
the transcriptional repression of the small RNR subunit gene in G1
phase (7, 8). In addition to transcriptional regulation, in Saccha-
romyces cerevisiae and Schizosaccharomyces pombe RNR activity is
controlled by small proteins called Sml1 and Spd1, respectively, that
bind to RNR in G1 phase and inhibit its activity (9–11). Sml1 and
Spd1 are degraded upon entry into S phase or in response to DNA
damage (9, 12). Finally, in both yeasts the RNR activity is reported
to be controlled by differential localization of its subunits during the
cell cycle and after DNA damage (9, 13–15).
The significance of the elimination of RNR activity in G1 phase
is not clear, especially in cycling yeast cells, where G1 phase is short.
The dATP feedback inhibition would restrict the RNR activity and
therefore couple dNTP concentration to utilization, even if a fully
active enzymewere present inG1 phase. The consumption of dNTP
during G1 phase is minimal and is limited to mitochondrial DNA
synthesis and repair. The deoxyribonucleosides produced by 5-
nucleotidases in mammalian cells are able to penetrate the cellular
membrane and can be excreted (1), but no degradation of excess
deoxyribonucleotides to deoxyribonucleosides or excretion is doc-
umented in yeast. Yeast, unlike mammalian cells, also lacks de-
oxynucleoside kinases, which together with deoxynucleotidases
form a substrate cycle important for regulation of [dTTP] (1, 16).
It is usually assumed that elimination of RNR activity ensures that
unscheduled DNA replication does not occur in G1, but there are
no data supporting this notion.
To understand the role of [dNTP] fluctuation during the cell
cycle, we chose S. cerevisiae as a model organism, where both cell
cycle and RNR biology are well studied. In S. cerevisiae [dNTP]
increases in response to DNA damage up to 8-fold above [dNTP]
of a logarithmically growing culture (17). This increase is mediated
by the Mec1/Rad53 DNA damage checkpoint, which activates
transcription of the RNR genes and promotes degradation of the
inhibitory protein Sml1 (11, 18, 19).
The increase in [dNTP] in S. cerevisiae during DNA damage is
directly correlated to DNA damage tolerance (17). In the rnr1-
D57N strain, in which the dATP feedback inhibition of RNR is
nonfunctional, [dNTP] transiently increases in response to DNA
damage30-fold. The ability of the rnr1-D57Nmutant to increase
[dNTP] above wild-type levels in response to DNA damage is
associated with an up to 500-fold higher tolerance of DNA damage
(17). It is not known whether a constant presence of an 30-fold
higher [dNTP] during the cell cycle also increases DNA damage
survival.
To study the effect of continuously high [dNTP] on the DNA
damage checkpoint and cell cycle progression, we introduced into
the yeast genome an additional RNR1 or rnr1-D57N allele, both
under the regulation of the inducible GAL1 promoter. Expression
of the GAL1-driven rnr1-D57N allele resulted in an 35-fold
increase in [dNTP], similar to the increase in the rnr1-D57N strain
during a DNA damage response, whereas expression of theGAL1-
driven wild-type RNR1 resulted in an10-fold increase in [dNTP],
similar to the increase in a wild-type strain during DNA damage
response. The continuous overexpression of rnr1-D57N delayed cell
cycle progression, particularly entry into S phase, delayed activation
of prereplicative complexes (pre-RCs) at origins of DNA replica-
tion, and also resulted in DNA damage sensitivity due to a defect
in the DNA damage checkpoint response. When the number of
pre-RCs was reduced by mutations in the origin recognition
complex, cells were sensitive to overexpression of wild-type RNR1.
These results suggest that [dNTP] controls cell cycle progression by
regulation of pre-RC utilization during normal growth and during
a response to DNA damage.
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Results
Expression of RNR1 Alleles Increases [dNTP] in the Absence of DNA
Damage. The GAL1-regulated RNR1 or rnr1-D57N alleles were
integrated at theURA3 locus of a wild-typeW1588-4C S. cerevisiae
strain. After 3 h of induction by galactose (gal), [dNTP] propor-
tionally increased9–10 times in the pGAL-RNR1 strain and35
times in the pGAL-rnr1-D57N strain (Fig. 1A). Induction of both
strains also resulted in a decrease in [NTP], a 1.2- to 1.8-fold
decrease in the pGAL-RNR1 strain, and a 1.3- to 2.2-fold increase
in the pGAL-rnr1-D57N strain (Fig. 1B). The same changes in
[dNTP] and [NTP] were found in both strains growing logarith-
mically in gal-containing media for more than six doubling times
(data not shown). Thus, expression of RNR1 alleles results in a
sustained increase in dNTP concentration even in the absence of
DNA damage. The increases in [dNTP] in pGAL-RNR1 and
pGAL-rnr1-D57N were of the same magnitude as in the DNA-
damage-treatedwild-type and rnr1-D57N strains (where rnr1-D57N
is under its own promoter), respectively (17).
Expression of rnr1-D57N Causes Slow Proliferation but Does Not
Activate the DNA Damage Checkpoint. Whereas the expression of
RNR1hadno effect on the proliferation rate of yeast, the expression
of rnr1-D57N slowed it down. The plating efficiency was, however,
the same among the strains with a pGAL promoter only, pGAL-
RNR1, or pGAL-rnr1-D57N on YPD and YPGal (data not shown
and Fig. 2A), demonstrating that the overexpression of the Rnr1-
D57N is not toxic. Gal induction slowed proliferation of the
pGAL-rnr1-D57N strain (Fig. 2A), and flow cytometry showed an
enrichment of cells in G1 phase or at the G1/S transition, but most
notably a reduction of the number of cells in S phase (Fig. 1C). This
change in cell cycle distribution did not occur when RNR1 was
induced (Fig. 1C).
It is possible that the slow proliferation of the gal-induced
pGAL-rnr1-D57N strain is caused by the 2-fold decrease in
[NTP]. In this case the rate of transcription in the pGAL-rnr1-D57N
strain should be reduced after induction. To test this possibility, we
compared the rate of synthesis of rRNA in the pGAL, pGAL-
RNR1, and pGAL-rnr1-D57N strains with and without induction.
There was no difference in the amount of rRNA or rRNA synthesis
rate in the pGAL-rnr1-D57N strain with and without induction
(Fig. 1 D–F). These results suggest that it is not the depletion of
NTP that caused the slow proliferation of the pGAL-rnr1-D57N
strain by blocking transcription.
Hydroxyurea inhibits RNR activity and depletes the dNTP pool,
causing activation of the Mec1/Rad53 checkpoint and cell cycle
arrest in early S phase (20). It is possible that the unusually high
[dNTP], like the unusually low [dNTP] caused by hydroxyurea,
interferes with DNA replication by activating the DNA damage
checkpoint and arresting cell cycle progression. Activation of the
DNA damage checkpoint leads to phosphorylation of the Rad53
protein, resulting in an electrophoretic shift of the Rad53 (21, 22).
The activatedMec1/Rad53 checkpoint also induces transcription of
all RNRgenes, notablyRNR3 (19).NeitherRad53 phosphorylation
(Fig. 3A) nor an increase of Rnr3 (Fig. 3B) was observed in the
gal-induced pGAL-rnr1-D57N strain, suggesting that the slower
rate of S-phase progression was not due to activation by high
[dNTP] of the known intra-S-phase DNA damage checkpoint
pathway.
Continuous Expression of rnr1-D57N Inhibits the DNA Damage Check-
point. An 30-fold increase in [dNTP] during DNA damage in a
yeast strain with an rnr1-D57N allele under its own promoter is
associated with an increased DNA damage tolerance (17). In
contrast, the pGAL-rnr1-D57N strain, although it also increases
[dNTP] 35-fold when grown on gal, is DNA-damage-sensitive
(Fig. 2A). Thus, such a high [dNTP] is deleterious when present
continuously, but a transient induction of the same [dNTP] is
beneficial for DNA damage survival. The pGAL-RNR1 strain was
more resistant toDNAdamage onYPGal compared with wild type
(Fig. 2A) and approximately as resistant toDNAdamage as a strain
with an rnr1-D57N allele under its own promoter (17).
Consistent with the DNA-damage-sensitive phenotype of the
pGAL-rnr1-D57N strain on YPGal, Rad53 was not activated, and
the cell cycle was not arrested by DNA-damaging agents (Fig. 2 B
and C). In the presence of methyl methanesulfonate (MMS), only
a small percentage of the gal-induced pGAL-rnr1-D57N cells
slowed down S-phase progression, whereas the bulk of the cells
Fig. 1. Expression ofRNR1alleles increases [dNTP] and decreases [NTP] but does
not affect transcription. (A) Changes in [dNTP] in pGAL-RNR1 and pGAL-rnr1-
D57N strains after a 3-h gal induction. [dNTP] in the wild-type W1588-4C strain
was assigned a value of 1. (B) [NTP] in pGAL-RNR1 (AC438) and pGAL-rnr1-D57N
(AC439) strains after a 3-h gal induction, in percentage of [NTP] in a wild-type
strain. (C–F) pGAL (AC437), pGAL-RNR1 (AC438), and pGAL-rnr1-D57N (AC439)
strains were grown in minimal media without methionine until an OD600 of 0.2
and after the addition of 2% gal or raf incubated for 4 h. (C) Flow-cytometric
analysis of pGAL (Left), pGAL-RNR1 (Center), and pGAL-rnr1-D57N (Right). (D)
Ethidium bromide staining showing equal amounts of 25S and 18S rRNA. (E and
F) Ethidium bromide staining (E) and corresponding autoradiography (F) of the
[3H]methionine-labeled rRNA sample from the pGAL-rnr1-D57N (AC439) strain.
 and indicate presence and absence of gal.
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continued to slowly progress through the cell cycle (the OD of the
culture continued to increase slowly during the 5-h time course). In
the same strain, in the absence of high [dNTP], MMS induced the
checkpoint and cells progressed very slowly through S phase (Fig.
2 B and C).
Expression of rnr1-D57N from GAL1 Promoter Reduces Cdc45 Loading
onto Chromatin.High [dNTP] slows down progression into S phase.
This may be because of inefficient assembly of pre-RCs at origins
ofDNA replication that normally occurs inG1 phase, when [dNTP]
normally is low. Alternatively, pre-RC assembly might be normal,
but activation of these licensed origins might be inefficient in the
presence of high [dNTP].
To test these contrasting ideas, the pGAL-rnr1-D57N strain was
synchronized either in late G1 phase by  factor or in mitosis using
a dbf2-1 ts mutation. The -factor-synchronized cells not induced
by gal progressed normally through the cell cycle, whereas the
gal-induced cells showed a delayed entry into S phase and a delayed
and reduced loading of Cdc45, a preinitiation complex (pre-IC)
protein (23), onto chromatin (Fig. 4A). The dbf2-1 pGAL-rnr1-
D57N cells both induced and not induced by gal exited frommitosis
at the same rate, but the gal-induced cells again showed delayed
S-phase entry and reduced Cdc45 loading (Fig. 4B). Levels of
chromatin-boundMcm2 were not dramatically different, except for
a delay in Mcm2 removal from chromatin in the presence of high
[dNTP], consistent with a delay in passage through S phase (Fig. 4).
The dynamics of new bud appearancewas similar in the gal-induced
dbf2-1 pGAL-RNR1 and dbf2-1 pGAL-rnr1-D57N strains after
release from the mitotic arrest [supporting information (SI) Fig. 6].
Induced pGAL-RNR1 Is Synthetic Sick with orc2-1 and orc5-1. It is
known that the number of origins of DNA replication in yeast are
in excess of what is normally required to complete S phase (24).
Because constitutive, high [dNTP] blocked initiation of DNA
replication from the normal number of pre-RCs and slowed cell
proliferation, we predicted that lowering the number of pre-RCs
might further compromise cell proliferation in the presence of high
dNTP. A low number of active origins of DNA replication are
present in strains harboring mutations in origin recognition com-
plex subunits, such as orc2-1 and orc5-1, even when grown at a
permissive or semipermissive temperature (25).
Moderate [dNTP] that do not block cell cycle progression in
wild-type strains were induced in orc2-1 or orc5-1 strains containing
pGAL-RNR1. In both cases a synthetic sickness was observed (Fig.
5 A and B), suggesting that S-phase progression from a limited
number of origins is sensitive to even moderately elevated [dNTP].
Induction of pGAL-rnr1-D57Nwas synthetic lethal with both orc2-1
(data not shown) and orc5-1mutants [Fig. 5C; note that at 33°C the
Fig. 2. Expression of pGAL-rnr1-D57N leads to DNA damage sensitivity and
defects in DNA damage checkpoint. (A) Overnight cultures of pGAL (AC437),
pGAL-RNR1 (AC438), and pGAL-rnr1-D57N (AC439) strains grown in YPD were
spotted at 10-fold serial dilutions on YPD, YPGal, and YPGal/0.3 mg/4-
nitroquinoline 1-oxide plates. (B) pGAL-rnr1-D57N (AC439) strain was grown in
YPRaf to an OD600 of 0.2, and half of the culture was induced by 2% gal for 2 h
(indicatedby).After that,0.01%MMSwasadded(indicatedby), andsamples
were collected for analysis by Western blotting (Upper) and SDS/PAGE (Lower) at
45 and 90 min. (C) pGAL-rnr1-D57N (AC439) strain was grown in YPRaf to an
OD600 of 0.2, and half of the culture was induced by 2% gal for 2 h (indicated by
GAL). After that, 0.01% MMS was added (indicated byMMS), and samples were
collected for flow-cytometric analysis.
Fig. 3. Expression of pGAL-rnr1-D57N does not activate Rad53 and does not
induce transcription of RNR3. (A) pGAL (AC437) and pGAL-rnr1-D57N (AC439)
strains were grown in YPRaf to an OD600 of 0.2, and, after the addition of
either 0.01% MMS, 2% gal, or no addition of drug, they were incubated for
3 h. The expression of Rnr1-D57N was analyzed by SDS/PAGE (Upper) and
Rad53 phosphorylation by Western blotting (Lower). M, protein marker lanes.
(B) pGAL-rnr1-D57N RNR3-HA (AC454-4F) strain was grown in liquid YPRaf to
an OD600 of 0.2, and, after the addition of either 0.3 mg of 4-nitroquinoline
1-oxide, 2% gal, or no addition of drug, they were incubated for 3 h. The
expression of Rnr1-D57N was analyzed by SDS/PAGE (Upper), and the expres-
sion of Rnr3-HA was analyzed by Western blotting (Lower).
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pGAL-rnr1-D57N strain grows slightly faster than at 28–30°C,
perhaps because of a lower RNR activity at higher temperatures
(26)]. These results further suggest that activation of origins ofDNA
replication is sensitive to preexisting high [dNTP].
Discussion
To understand the role of [dNTP] fluctuation during the cell cycle,
we overexpressed a wild-type and an overactive RNR. Expression
of RNR1 resulted in a 9- to 10-fold increase in [dNTP] and a 1.2-
to 1.8-fold decrease in [NTP], but no apparent growth defects.
Expression of the overactive rnr1-D57N resulted in an 35-fold
increase in [dNTP], a 1.3- to 2.2-fold decrease in [NTP], retardation
of cell proliferation, and defects in the DNA damage checkpoint.
Because the difference in [dNTP] between the gal-induced pGAL-
RNR1 and pGAL-rnr1-D57N strains was significantly bigger than
the difference in [NTP] in these strains and because we found no
defects in the rate of rRNA production in the induced pGAL-rnr1-
D57N strain, we suggest that the proliferation defects observed in
the pGAL-rnr1-D57N strain are mainly due to the higher [dNTP]
and not the lower [NTP].
A transient 30-fold increase in [dNTP] in response to DNA
damage in the strain with the rnr1-D57N allele under its own
promoter increases DNA damage tolerance but does not cause cell
proliferation defects (17). Thus, it is not the high [dNTP] per se, but
its continuous presence during the cell cycle that is deleterious to
cell proliferation. The flow-cytometric analysis of the pGAL-rnr1-
D57N strain with high [dNTP] showed that cells accumulate in G1
phase, where the [dNTP] is usually low. An important process that
can occur only in G1 phase is the assembly of DNA replication
origins.We found that high [dNTP] inG1 phase did not significantly
inhibit minichromosome maintenance proteins loading onto chro-
matin, and hence pre-RC assembly was most likely normal. But
activation of pre-RCs was defective based on the slow assembly of
Cdc45, a component of the pre-IC, onto chromatin. Even a
moderate increase in [dNTP] after the pGAL-RNR1 induction
resulted in synthetic sickness in the origin recognition complex
mutants orc2-1 and orc5-1.Although we cannot completely exclude
that the observed phenotypes are not due to some unknown activity
of the Rnr1 protein, we propose that it is the continuously high
[dNTP] present in the induced pGAL-RNR1 and pGAL-rnr1-
D57N strains that affects processes regulated by dNTP in G1 and
early S phase.
DNA damage activates RNR in different phases of the cell cycle
including G1 (19). Because high [dNTP] inhibits pre-IC assembly
Fig. 4. Loading of Cdc45 onto chromatin is inhibited by expression of pGAL-rnr1-D57N. (A) pGAL-rnr1-D57N (AC439) strain was treated as shown in the outline.
The samples were collected at 10-min intervals for analysis of Cdc45 and Mcm2 association with chromatin and for flow-cytometric analysis. (B) The
pGAL-rnr1-D57N dbf2-1 (AC473) strain was treated as shown in the outline. The samples were collected at 10-min intervals for analysis of Cdc45, Mcm2, Orc3,
and Orc5 association with chromatin and for flow-cytometric analysis.
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and hence activation of existing pre-RCs, an elevated [dNTP] in G1
phase, such as occurs after DNA damage, might be one of the
effectors that delays entry into S phase. These observations may
explainwhy there aremultiple regulatorymechanisms to limitRNR
activity in G1 phase.
It is apparent that the constant, high [dNTP] blocks DNA
replication in the absence of theRad53-dependent checkpoint.One
possibility is that the checkpoint may not be induced because of the
low number of origins that are activated in S phase. For example,
when cells traverse S phase with a suboptimal number of replication
forks, they are unable to activateRad53 andbecomeDNA-damage-
sensitive (27, 28). Alternatively, the S-phase DNA damage check-
point may be inhibited by the constitutive, high [dNTP] directly
blocking Rad53 activation, perhaps by feedback inhibition. It could
be that, in the presence of constitutive, high [dNTP], the checkpoint
cannot get started. Whatever the mechanism, the observation that
the DNA damage checkpoint is inactive in the presence of high
[dNTP] explains why such cells are sensitive to DNA-damaging
reagents. But these results also suggest that dNTPs inhibit initiation
of DNA replication by a checkpoint-independent process that
regulates pre-IC assembly.
In wild-type strains the [dNTP] present after DNA damage is
4-fold above [dNTP] in an unperturbed S phase (17). It is
important to note, however, that this dNTP induction is transient.
The elevated [dNTP] present after DNA damage in S phase may
be one of the direct cellular signals that blocks activation of
downstream pre-RCs or helps to maintain these pre-RCs in an
inactive state, thereby preventing initiation of DNA replication on
damaged templates until the repair is completed. Once [dNTP]
returns to normal and the checkpoint is no longer functioning,
activation of pre-RCs that have not yet been used in S phase
facilitates the completion of DNA replication.
Can dNTP function as regulatory molecules in vivo? There are
several examples of proteins that have higher affinity to dNTP
compared with NTP and that become activated at lower [dNTP]
than corresponding [NTP]. A key regulator of apoptosis, Apaf-1, is
activated by lower [dATP] than [ATP] in vitro and was reported to
bind dATP and not ATP in vivo (29, 30). Recently, both dATP and
ATP were shown to bind cytochrome c and prevent its activation of
Apaf-1 (31). The activity of RecA, a regulator of DNA recombi-
nation in bacteria, is enhanced if dATP is used in vitro in place of
ATP (32, 33).
What might be the targets for dNTPs blocking pre-IC assembly?
It is possible that S-phase cyclin-CDK (Clb5/6-Cdc28) and Cdc7-
Dbf4 required for activation of pre-IC are inhibited by dNTP.
Cdc7/Dbf4 kinase has been implicated as a target of the Rad53-
dependent intra-S-phase checkpoint response by blocking activa-
tion of pre-RCs that have not fired, although a Cdc7-independent
checkpoint pathway exists (34). This alternative pathway might
involve Mcm10 or primase, both of which are required for origin
activation and have a nucleotide binding site. Mutations in primase
and its associated DNA polymerase  have been implicated in the
intra-S-phase checkpoint (35, 36). Finally, because the pre-RC
proteins, including origin recognition complex, Cdc6, and
minichromosome maintenance proteins, bind nucleotide, high
[dNTP] might block their activation in the pre-RC.
Is continuous RNR/dNTP presence deleterious in higher eu-
karyotes? In mammalian cells, the cell cycle-regulated component
of RNR is the small subunit calledR2 (1, 37). It is ubiquitylated and
degraded by anaphase-promoting complex-Cdh1/proteasome in
mitosis and resynthesized in the late G1 phase after its transcription
is derepressed (7, 8, 38). Interestingly, although it is easy to obtain
R2-expressing untransformed fibroblasts by transformation with
the full R2 gene under its own, cell cycle-regulated promoter,
numerous attempts to express R2 protein in untransformed fibro-
blasts using R2 cDNA under SV40 promoter failed (L. Thelander,
personal communication). It has been proposed that constant
expression of R2 protein from the SV40 early promoter is lethal to
cells, but no mechanism for this lethality has been proposed (39).
This observation suggests that also in mammalian cells the un-
scheduled expression of RNR is incompatible with normal cell
proliferation.
In contrast to dATP, dCTP, and dGTP, the concentration of
dTTP is regulated not only by RNR, but also by dCMP deaminase
and thymidylate kinase (TMPK). This is because there is no rTDP
precursor in vivo and dTTP is made from dUDP or dCDP first
produced byRNR(1). In addition, inmammalian cells the substrate
cycle (phosphorylation of thymidine by thymidine kinases and
degradation of dTMP by 5-deoxynucleotidases), together with
thymidine phosphorylase, plays an important role in the regulation
of [dTTP] (1, 16, 40). Interestingly, human thymidine kinase TK1
and TMPK are also targets for the anaphase-promoting complex/C
pathway and, similar to RNR, are degraded in late mitosis (41, 42).
Overexpression of the wild-type TK1 and TMPKdid not inhibit cell
growth, whereas overexpression of the nondegradable TK1 and
TMPK led to a severe growth retardation (42). The levels of the
wild-type and nondegradable proteins were similar, suggesting that
it was the presence of TK1 and TMPK proteins in G1 phase that led
to growth inhibition. The authors attributed slow cell proliferation
to the severe imbalance of dNTP pools in the cells expressing
nondegradable proteins, but, in light of our results, it is also possible
that the presence of high [dTTP] in G1 phase affected activation of
replication origins in mammalian cells.
A recent report has demonstrated an intimate link between
dNTP production and the initiation of DNA replication in Esche-
richia coli, but in this case initiation ofDNA replication controls the
synthesis of RNR subunit transcription, linking activation of the
initiation complex to dNTP production (43). In S. cerevisiae the link
between dNTP production and origin activation may be a two-way
interaction. It will be interesting to analyze the effects of increased
Fig. 5. Elevation of [dNTP] results in synthetic sickness or lethality in the orc2-1
and orc5-1 mutants. (A) Wild-type (AC476-1D), orc2-1 (AC476-1A), orc2-1 sml1
pGAL-RNR1 (AC476-5B), and sml1 pGAL-RNR1 (AC475-4I) strains were streaked
on YPGal and incubated at 24°C. (Right) A magnification showing synthetic
sickness of orc2-1 plus pGAL-RNR1 (slower growth, uneven colonies). (B) orc5-1
(AC474-3H), orc5-1 sml1 pGAL-RNR1 (AC474-3G), and sml1 mec1 pGAL-RNR1
(AC474-3F) strains were streaked on YPGal and incubated at 33°C. (C) Wild-type
(AC459-1A), orc5-1 pGAL-rnr1-D57N (AC459-1D), orc5-1(AC459-1C), and pGAL-
rnr1-D57N (AC459-1B) strains were streaked on YPGal and incubated at 33°C.
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[dNTP] on the activation of pre-RC in organisms that do not
increase [dNTP] after DNA damage above the S-phase concen-
tration, like S. pombe and the mammalian fibroblasts (10, 44). In
these cells even a moderate increase of [dNTP] might be affecting
the activation of pre-RC.
Materials and Methods
Yeast Strains andMedia.Yeasts were grown inYP (1%yeast extract,
2% peptone) with 2% dextrose (YPD), 2% galactose (YPGal), or
2% raffinose (YPRaf). To construct pGAL, pGAL-RNR1, and
pGAL-rnr1-D57N strains, RNR1 and rnr1-D57N were PCR-
amplified by using previously described pET21a-RNR1 and pET3a-
rnr1-D57N plasmids as templates (17) and cloned in the pESC-
URA vector (Stratagene, La Jolla, CA) between BamHI and KpnI
restriction sites. To remove the 2 origin, the vectors were digested
with AfeI, purified by electrophoresis, and ligated. The resulting
vectors were linearized in theURA3 gene by digestionwith StuI and
transformed into W1588-4C. The C-terminally HA-tagged RNR3
was constructed by a one-step PCR-mediated technique (45). After
transformation all stains were confirmed by PCR and back-crossed
to W1588-4A. Other strains listed in SI Table 1 were obtained by
standard genetic manipulations.
dNTP and NTP Analysis. Isolation of nucleotides from yeast was done
as described (17). dNTP and NTP were analyzed by HPLC on a
PolyWAX LP column (PolyLC, Columbia, MD) by using a UV-
2075 Plus detector (Jasco, Tokyo, Japan). Nucleotides were iso-
cratically eluted with 2.5% acetonitrile/0.3 M potassium phosphate
(pH 5.0) buffer.
Flow Cytometry. Samples for flow cytometry were prepared as
described in ref. 46 and analyzed on a Cytomics FC500 (Beckman
Coulter, Fullerton, CA) or a LSR II (Becton Dickinson).
RNA Isolation and Labeling. RNA isolation and labeling were done
as described (47–49). Cells were collected by centrifugation and
resuspended in 0.5 ml of buffer (50 mM sodium acetate, 10 mM
EDTA, and 0.1% SDS). RNA was extracted with 0.5 ml of phenol
preheated to 65°C, followed by phenol-chloroform (1:1) preheated
to 65°C. RNA was precipitated by ethanol, fractionated on a 1.5%
agarose gel containing 6.7% formaldehyde, and stained by
ethidium bromide. For rRNA labeling, the induced and uninduced
pGAL-rnr1-D57N cultureswere adjusted to anOD600 of 0.4, and 1.5
ml was incubated with L-[methyl-H3]-methionine [60 Ci/ml final
concentration (1 Ci 37 GBq)] for 5 min. The gel was stained with
ethidium bromide, photographed, treated with EN3HANCE
(PerkinElmer, Wellesley, MA), dried, and exposed to film with an
enhancer screen at 80°C.
Chromatin Binding Assay. Yeast cells were synchronized by temper-
ature arrest or -factor arrest as outlined in Fig. 4. The cells were
centrifuged, resuspended in 1 ml of CSB buffer (100 mM
PipesKOH, pH 9.4/10 mM DTT), and incubated at 30°C for 10
min. After 2 min of centrifugation at 2,000  g, the cells were
resuspended in 1 ml of SB buffer (50 mM phosphate buffer, pH
7.5/0.6 M sorbitol/10 mM DTT), and, after addition of 40 l of
zymolyase (2 mg/ml in 1 M sorbitol), incubated for 15 min at 30°C.
The spheroplasts were centrifuged for 2 min at 2,000  g, resus-
pended in 1 ml of ice-cold SWB buffer [50 mM HepesKOH, pH
7.5/2.5mMMgCl2/0.4M sorbitol/protease inhibitors (Roche, Basel,
Switzerland)], and centrifuged for 2 min at 2,000  g. The pellets
were resuspended in 40 l of ice-cold EB buffer [100 mM KCl/50
mM HepesKOH, pH 7.5/2.5 mM MgCl2/0.25% Nonidet P-40/
protease inhibitors (Roche)] and underlaid with 20 l of 30%
sucrose. After 10 min of centrifugation at 10,000  g, pellets were
washed with EB buffer, resuspended in 40 l of EB buffer, mixed
with 40 l of SDS/PAGE loading buffer, and boiled.
Western Blotting. For Rad53 detection, yeast cells were lysed as
described (50) and analyzed with an anti-Rad53 FHA1(20–164)
rabbit polyclonal antibody (1:5,000). For Rnr3-HA detection, pro-
tein extract was prepared as described (51) and used with anti-HA-
tag 12CA5 mouse monoclonal antibody (1:5,000). For analysis of
the chromatin-bound Cdc45, Mcm2, Orc3, and Orc5, chromatin
fractions were probed with anti-Cdc45 CS1485 rabbit polyclonal
antibody (0.5 g/ml), anti-Orc3 SB3 mouse monoclonal antibody
(1:2,000), anti-Mcm2 mcm2–39 mouse monoclonal antibody
(1:2,000), and anti-Orc5 SB5mousemonoclonal antibody (1:4,000).
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